×
For best experience we recommend to activate Javascript in your browser.
Dopamine d2 Receptor antibody (C-Term)
DRD2
Reactivity: Human, Mouse
WB, EIA
Host: Rabbit
Polyclonal
unconjugated
Product Details anti-Dopamine d2 Receptor Antibody
(hide)
Target
See all Dopamine d2 Receptor (DRD2) Antibodies
Dopamine d2 Receptor (DRD2)
(Dopamine Receptor D2 (DRD2))
Binding Specificity
All epitopes for Dopamine d2 Receptor antibodies
AA 306-336, C-Term
Reactivity
All reactivities for Dopamine d2 Receptor antibodies
Human, Mouse
Host
All hosts for Dopamine d2 Receptor antibodies
Rabbit
Clonality
All clonalities for Dopamine d2 Receptor antibodies
Polyclonal
Conjugate
All conjugates for Dopamine d2 Receptor antibodies
This Dopamine d2 Receptor antibody is un-conjugated
Application
All applications for Dopamine d2 Receptor antibodies
Western Blotting (WB), Enzyme Immunoassay (EIA)
Specificity
This antibody recognizes Human and Mouse Dopamine D2 receptor (C-term).
Purification
Affinity Chromatography on Protein A
Immunogen
KLH conjugated synthetic peptide between 306-336 amino acids from the C-terminal region of Human Dopamine D2 receptor. Genename: DRD2
Isotype
Ig Fraction
Top Product
Discover our top product DRD2 Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.25 mg/mL
Buffer
PBS with 0.09 % (W/V) Sodium Azide as preservative
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freezing and thawing.
Storage
4 °C/-20 °C
Storage Comment
Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Target Details for Dopamine d2 Receptor
(hide)
Target
Dopamine d2 Receptor (DRD2)
(Dopamine Receptor D2 (DRD2))
Alternative Name
Dopamine D2 Receptor (DRD2 Products )
Synonyms
D2DR antibody, D2R antibody, drd2b antibody, d2r2 antibody, Drd-2 antibody, d2dr antibody, d2r antibody, drd2 antibody, drd2-B antibody, DRD2 antibody, D2 antibody, CG18741 antibody, CG7569 antibody, DAMB antibody, DDR2 antibody, DOPR2 antibody, DOPR99B antibody, Dar2 antibody, Dmel\\CG18741 antibody, DopD1 antibody, DopR99B antibody, DopRII antibody, dopamine receptor D2 antibody, dopamine receptor D2 like antibody, dopamine receptor D2 L homeolog antibody, dopamine receptor D2 S homeolog antibody, Dopamine 1-like receptor 2 antibody, DRD2 antibody, drd2l antibody, drd2 antibody, Drd2 antibody, drd2.L antibody, drd2.S antibody, Dop1R2 antibody
Background
This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia, other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.Synonyms: D(2) dopamine receptor, DRD2
Molecular Weight
50619 Da
Gene ID
1813
NCBI Accession
NP_000786
Pathways
Positive Regulation of Peptide Hormone Secretion , Negative Regulation of Hormone Secretion , cAMP Metabolic Process , Inositol Metabolic Process , Regulation of G-Protein Coupled Receptor Protein Signaling , Feeding Behaviour , Negative Regulation of Transporter Activity , Regulation of long-term Neuronal Synaptic Plasticity
Recently viewed
(hide)